Jin'ge pill sales reach new highs amid demand spike

Jin'ge is the Chinese version of Viagra, launched by Guangzhou Baiyunshan Pharmaceutical in 2014. The company sold more than 78 million Jin'ge pills in 2020, with revenue reaching 833 million yuan.

Pfizer Wins Landmark Viagra Ruling in China - S&P Global

A Chinese court overturned a patent challenge from local manufacturers of generic Viagra in 2006, upholding Pfizer's IP rights. The decision was a signal of improving IP protection in China, but did not affect the market for fake versions of the drug.

Guangdong: Chinese Viagra to Hit Market - cnipa.gov.cn

Guangzhou Baiyunshan Pharmaceutical Holdings Co announced that it would launch Jinge, the Chinese version of Viagra, by the end of October. Baiyunshan is the nation's first company to receive approval from the China Food and Drug Administration to make sildenafil citrate, a generic erectile dysfunction medicine, after US based Pfizer Inc's patent for the medicine, under the brand name Viagra ...

As Viagra Patent Expires, Chinese Company Creates New ED Generic

BEIJING — After a development period of more than 10 years, and with final approval from the China Food and Drug Administration, Guangzhou Baiyunshan Pharmaceutical Co. has just launched a generic erectile dysfunction drug based on Viagra, to be sold at half the price.. At the press conference for the launch of "Jinge" (literally meaning "gold dagger"), Baiyunshan deputy director Wang Wenchu ...

Chinese Drug Company wins approval to make Generic Version of Viagra

Guangzhou Baiyunshan Pharmaceutical is the first official producer of a homegrown version of Viagra in China, after Pfizer's patent expired in May. The company plans to sell its product "Jin Ge" at a lower price than Viagra and compete with other generic versions in the growing erectile dysfunction market.